Posts

Showing posts with the label Optic Nerve Disorders Treatment Market share

Optic Nerve Disorders Treatment Market to Witness Robust Growth Due To Increasing Prevalence of Eye Disorders

Image
  Optic nerve disorder is a rare autoimmune disease that indicates degeneration of the optic nerve. There are many types of optic nerve disorders, such as optic nerve atrophy, optic neuritis, and glaucoma. An individual with glaucoma can use eye drops, take oral medications, or undergo eye surgery such as laser therapy. Antibiotics such as tetracycline, isoniazid, and ethambutol cause optic neuritis. In some cases, steroid-based medications are used to reduce inflammation in the optic nerve. However, once damaged, the optic nerve cannot be repaired since the damage is irreversible. The optic nerve disorders treatment market is expected to witness robust growth due to increasing prevalence of the disease. Glaucoma is the second most common cause of blindness globally. According to the Glaucoma Research Foundation (GRF), a national non-profit organization, by 2040, around 1,118 million people worldwide will have glaucoma. According to the World Health Organization (WHO), there are ...